Keith Regnante - Insider Trading & Ownership

Entity
Individual
Location
733 Concord Avenue, Cambridge, MA
All Insider Reports
All Insider Reports

Ownership of Keith Regnante

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KROS Keros Therapeutics, Inc. Chief Financial Officer -$1.81M Feb 13, 2024

Insider Transactions Reported by Keith Regnante:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.